Articles with public access mandates - Thomas SECHERLearn more
Not available anywhere: 4
The regenerating family member 3 β instigates IL-17A-mediated neutrophil recruitment downstream of NOD1/2 signalling for controlling colonisation resistance independently of …
N Waldschmitt, S Kitamoto, T Secher, V Zacharioudaki, O Boulard, ...
Gut 68 (7), 1190-1199, 2019
Mandates: Agence Nationale de la Recherche
Barriers for orally inhaled therapeutic antibodies
T Sécher, N Heuzé-Vourc’h
Expert Opinion on Drug Delivery 20 (8), 1071-1084, 2023
Mandates: European Commission, Agence Nationale de la Recherche
The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies
T Blin, C Parent, G Pichon, A Guillon, Y Jouan, H Allouchi, N Aubrey, ...
European Journal of Pharmaceutics and Biopharmaceutics 195, 114163, 2024
Mandates: Agence Nationale de la Recherche
Pulmonary Delivery of Antibody for the Treatment of Respiratory Diseases
T Sécher, N Heuzé-Vourc’h
Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines, 21-51, 2024
Mandates: European Commission, Agence Nationale de la Recherche
Available somewhere: 24
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
A Couturier-Maillard, T Secher, A Rehman, S Normand, A De Arcangelis, ...
The Journal of clinical investigation 123 (2), 2013
Mandates: US National Institutes of Health, German Research Foundation, National …
Toll-like receptor 2 is critical for induction of Reg3β expression and intestinal clearance of Yersinia pseudotuberculosis
R Dessein, M Gironella, C Vignal, L Peyrin-Biroulet, H Sokol, T Secher, ...
Gut 58 (6), 771-776, 2009
Mandates: National Institute of Health and Medical Research, France
Epithelial IL-23R signaling licenses protective IL-22 responses in intestinal inflammation
K Aden, A Rehman, M Falk-Paulsen, T Secher, J Kuiper, F Tran, ...
Cell reports 16 (8), 2208-2218, 2016
Mandates: US National Institutes of Health, German Research Foundation, Wellcome Trust …
IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice
R Guabiraba, AG Besnard, GB Menezes, T Secher, MS Jabir, SS Amaral, ...
Mucosal immunology 7 (5), 1079-1093, 2014
Mandates: Research Foundation (Flanders), UK Medical Research Council, Wellcome Trust
Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
C Massip, P Branchu, N Bossuet-Greif, CV Chagneau, D Gaillard, ...
PLoS pathogens 15 (9), e1008029, 2019
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Blockade of IL-1R signaling diminishes Paneth cell depletion and Toxoplasma gondii induced ileitis in mice
B Villeret, L Brault, A Couturier-Maillard, P Robinet, V Vasseur, T Secher, ...
American journal of clinical and experimental immunology 2 (1), 107, 2013
Mandates: US National Institutes of Health
Inhibitors of retrograde trafficking active against ricin and Shiga toxins also protect cells from several viruses, Leishmania and Chlamydiales
N Gupta, R Noël, A Goudet, K Hinsinger, A Michau, V Pons, H Abdelkafi, ...
Chemico-Biological Interactions 267, 96-103, 2017
Mandates: Swedish Research Council, UK Biotechnology and Biological Sciences Research …
Inhalation of immuno-therapeutics/-prophylactics to fight respiratory tract infections: an appropriate drug at the right place!
T Sécher, A Mayor, N Heuzé-Vourc'h
Frontiers in immunology 10, 2760, 2019
Mandates: Agence Nationale de la Recherche
Alternative routes of administration for therapeutic antibodies—state of the art
A Pitiot, N Heuzé-Vourc’h, T Sécher
Antibodies 11 (3), 56, 2022
Mandates: Agence Nationale de la Recherche
Correlation and clinical relevance of animal models for inhaled pharmaceuticals and biopharmaceuticals
T Sécher, E Bodier-Montagutelli, A Guillon, N Heuzé-Vourc’h
Advanced drug delivery reviews 167, 148-169, 2020
Mandates: Agence Nationale de la Recherche
The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice
T Secher, I Maillet, C Mackowiak, J Le Bérichel, A Philippeau, C Panek, ...
Scientific reports 8 (1), 11245, 2018
Mandates: National Institute of Health and Medical Research, France
In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration
T Secher, E Dalonneau, M Ferreira, C Parent, N Azzopardi, G Paintaud, ...
Journal of Controlled Release 303, 24-33, 2019
Mandates: Agence Nationale de la Recherche
Therapeutic antibodies–natural and pathological barriers and strategies to overcome them
Y Al Ojaimi, T Blin, J Lamamy, M Gracia, A Pitiot, C Denevault-Sabourin, ...
Pharmacology & therapeutics 233, 108022, 2022
Mandates: Agence Nationale de la Recherche
Aggregates associated with instability of antibodies during aerosolization induce adverse immunological effects
T Sécher, E Bodier-Montagutelli, C Parent, L Bouvart, M Cortes, ...
Pharmaceutics 14 (3), 671, 2022
Mandates: Agence Nationale de la Recherche
Remote control of intestinal tumorigenesis by innate immunity
T Secher, O Gaillot, B Ryffel, M Chamaillard
Cancer research 70 (5), 1749-1752, 2010
Mandates: National Institute of Health and Medical Research, France
MAIT cells display a specific response to type 1 IFN underlying the adjuvant effect of TLR7/8 ligands
M Pavlovic, C Gross, C Chili, T Secher, E Treiner
Frontiers in Immunology 11, 2097, 2020
Mandates: Agence Nationale de la Recherche
Publication and funding information is determined automatically by a computer program